Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Brief Report: Osimertinib Plus Capmatinib for Patients with MET-Altered EGFR-Mutant NSCLC Following Progression on Front Line Therapy

Omar Elghawy,Adam Barsouk, Lauren Reed-Guy,Margaret Stalker,Jonathan Sussman,Kyle Robinson,John Kosteva,Aditi Singh,Roger B. Cohen,Corey Langer,Christine Ciunci,Christopher D'Avella,Lova Sun,Melina E. Marmarelis,Charu Aggarwal

Clinical Lung Cancer（2024）

Cited 0|Views1
Key words
Non-small cell Lung Cancer,Osimertinib,Capmatinib,MET mutation,EGFR mutation,tyrosine kinase inhibitor
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined